Amarin Corp Plc (AMRN)

[ziploc_1]

cbd...BP continues to waste billions of dollars on the false premise that Alzheimers is due to amyloid deposits...Alzheimers is due to inflammation of the brain....Deposits of amyloid are the RESULT of inflammation of the brain...NOT THE CAUSE!.

By the time amyloid develops. it is already late in the game.This isn't to say that Vascepa, which has been proven safe and effective for CVD, can't also be of help in slowing the progress of this terrible disease!

The study (by Lilly) examined solanezumab in patients with amyloid plaque but no clinical Alzheimer's symptoms.

QUOTE from Lilly.."The A4 Study concludes our clinical development of solanezumab and indicates that targeting soluble amyloid beta through this mechanism is not effective in this population," said John Sims, Eli Lilly (NYSE:LLY) head of medical, global brand development "

This is where Vascepa,with its proven anti-inflammatory properties, can play a role!